Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2021, Issues FY 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Merit Medical Systems, Inc. (MMSI) PT Lowered to $73 at Needham & Company
February 25, 2022 6:33 AM ESTNeedham & Company analyst Mike Matson lowered the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $73.00 (from $83.00) while maintaining a Buy rating.
The analyst commented, "MMSI's 4Q21 revenue and EPS beat consensus. Revenue growth slowed slightly to 8.4% Y/Y in 4Q21 from 8.8%... More
Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 19c, Offers Guidance
February 24, 2022 4:43 PM ESTMerit Medical Systems Inc. (NASDAQ: MMSI) reported Q4 EPS of $0.71, $0.19 better than the analyst estimate of $0.52. Revenue for the quarter came in at $278.5 million versus the consensus estimate of $271.49 million.
GUIDANCE:
Merit Medical Systems Inc. sees FY2022 EPS of... More
